BRCA Gene Test - Indications, Uses, Drawbacks, and Role

What Is the BRCA Gene Test?

A BRCA (breast cancer gene) test is a clinical genetic test that looks for mutations in the breast cancer genes 1 and 2, which play an important role in protecting cells from becoming cancerous. Mutations in these genes or changes in the gene structure remarkably increase the risk of developing breast, ovarian, and other cancer types. Doctors usually advise BRCA testing for people who have a personal or family history of hereditary breast or ovarian cancer (HBOC). By identifying a BRCA1 or BRCA2 mutation, the test helps assess a person’s cancer risk more precisely, whether they will get it or not.

In this test, blood or saliva samples are used to check for these genetic changes. This test detects rarer variants in breast cancer genes whose impact on cancer risk is yet to be determined. Because BRCA results are difficult to explain, clinical geneticists convey the findings in a clear, consistent, and meaningful way to help patients understand their condition, risk, and next steps.

What Is the Role of the BRCA Gene Mutations in Breast Cancer?

BRCA1 and BRCA2 are important genes that help protect our cells from becoming cancerous. They act as DNA (deoxyribonucleic acid) repair genes, so they are also called tumor suppressor genes. When these genes work properly, they help prevent breast and ovarian cancers.

BRCA1 is present on chromosome 17, and BRCA2 on chromosome 13. When there is a harmful change or mutation in either of these genes, their protective function is lost. This increases the risk of cancers, especially breast and ovarian cancers. Women with a BRCA1 mutation have a high chance, around 60 to 80 percent, of developing breast cancer in their lifetime. Also, they are at a higher risk of ovarian cancer.

Men with BRCA1 or BRCA2 mutations may have a higher risk of prostate cancer, too. The BRCA2 mutation also increases the risk of breast cancer in men.

Breast cancers linked to BRCA1 mutations often behave more aggressively. They tend to grow faster, spread more easily, and are usually negative for ER (estrogen receptor), PR (progesterone receptor), and HER2 (human epidermal growth factor 2) receptors. These cancers also commonly show changes in another gene called p53.

People with BRCA1 or BRCA2 mutations may also have a higher chance of getting other cancers, such as colon, pancreatic, and gastric cancers, and melanoma.

There are over 2,000 known mutations in BRCA1 and BRCA2.

Most mutations are small changes, such as insertions (extra nucleotides) or deletions (loss of nucleotides), or problems in splicing that cause the gene to produce a shortened or non-functional protein. When the BRCA protein is defective, cells cannot repair DNA properly, increasing the risk of cancer.

What Happens if the BRCA Gene Test Is Positive?

A positive BRCA gene test means an abnormal mutation was found in either the BRCA1 or BRCA2 gene. This increases the risk of certain cancers, and the most common ones are breast and ovarian cancer.

Knowing about a BRCA mutation allows you or someone in your family to take proactive steps to reduce risk or detect cancer early.

These include:

• Regular cancer screenings.

• Enhanced surveillance techniques for high-risk individuals.

• Risk-reducing medications.

• Carefully considered use of birth control pills.

• Preventive or prophylactic surgery.

What Happens if the BRCA Gene Test Is Negative?

A BRCA test result that turns out negative means no harmful BRCA1 or BRCA2 mutation was detected. This also means that you or your loved one will not pass a BRCA mutation to your children.

However, a negative result does not eliminate the risk of cancer. Important points to consider are

• You may still be at risk if your family has a strong history of cancer.

• Other hereditary gene mutations beyond BRCA1 and BRCA2 may still be present and influence risk.

• A negative test does not mean there is no chance of a gene mutation that science has not yet discovered.

What Are the Indications for BRCA Gene Testing?

BRCA gene testing is advised for people who have a higher chance of carrying a hereditary cancer-related mutation.

Common indications for BRCA gene testing are:

• Breast cancer that is diagnosed in a woman aged 50 or younger.

• Multiple primary breast cancers.

• Triple-negative breast cancer (TNBC) diagnosed before age 60.

• Ovarian cancer.

• Someone in your family would have had breast, ovarian, pancreatic, or metastatic prostate cancer.

• A known BRCA mutation in the family.

• Decision-making for treatment, such as preventive surgery, targeted therapy decisions, and chemotherapy planning.

What Is the Use of the BRCA Gene Test?

The BRCA gene test is a key tool in diagnosing and managing hereditary cancer syndromes. Its uses are

• Identifying hereditary breast and ovarian cancer (HBOC) in both women and men.

• Detecting genetic risk for ovarian, pancreatic, and prostate cancer. Also for BRCA2-related melanoma.

• Guiding treatment decisions for certain therapies to work better in BRCA-mutated cancers.

• Improving cancer prevention strategies through enhanced screening and risk-reducing interventions.

• Supporting genetic counseling for families to understand inheritance patterns and cancer risk.

What Are the Challenges of BRCA Gene Testing?

BRCA genetic testing gives valuable information, but several challenges affect the interpretation and clinical decision-making:

• Genetic diversity across populations. Variations in BRCA gene frequency among different ethnic groups make interpretation more complex.

• Difficulty interpreting certain genetic alterations. Not all detected variants have clear clinical significance.

• Uncertainty with VUS (variants of uncertain significance) complicates clinical decision-making because cancer risk is unknown.

• There is a risk of misreading the VUS, which may make patient care difficult.

• There is only a five to twenty percent chance of an inherited VUS.

What Are the Drawbacks of BRCA Gene Testing?

The drawbacks are:

• BRCA testing and reporting are not standardized everywhere and may follow different standards.

• Laboratory classification and reporting methods may differ across different labs.

• Some BRCA variants require additional evidence for precise classification.

• There is a need for an integrated evaluation to resolve incompatible evidence.

• Functional assays and knowledge about BRCA1 and BRCA2 protein functions are limited.

Conclusion:

BRCA gene testing is a tool that helps us identify the risk of hereditary breast, ovarian, and other cancers. Spotting cancer-causing BRCA1 or BRCA2 mutations enables close observation, monitoring, informed decision-making, and the application of preventive strategies to reduce cancer risk. Although testing comes with some difficulties, it remains powerful in personalized treatment options and informed family health decisions. If you are recommended for genetic testing or have a family history of breast or ovarian cancer and are considering gene tests, ask a specialist for more information.

Key Takeaways:

1. BRCA testing helps identify hereditary cancer risk.

2. Results guide medical decisions such as treatments and risk prevention.

3. Guides through genetic counseling to understand the condition in a better way.